Thiotepa Patent Expiration

Thiotepa was first introduced by Immunex Corp in its drug Thiotepa on Approved Prior to Jan 1, 1982. Other drugs containing Thiotepa are Tepadina And Sodium Chloride, Thioplex, Tepadina, Tepylute. 14 different companies have introduced drugs containing Thiotepa.


Thiotepa Patents

Given below is the list of patents protecting Thiotepa, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tepylute US11975013 Stable formulations comprising thiotepa Aug 16, 2041 Shorla
Tepadina And Sodium Chloride US9931458 Multi chamber flexible bag and methods of using same May 31, 2037 Adienne Sa



Thiotepa's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Thiotepa Generic API Manufacturers

Several generic applications have been filed for Thiotepa. The first generic version for Thiotepa was by West-Ward Pharmaceuticals International Ltd and was approved on Apr 2, 2001. And the latest generic version is by Beloteca Inc and was approved on Aug 20, 2024.

Given below is the list of companies who have filed for Thiotepa generic, along with the locations of their manufacturing plants worldwide.